Prokidney

Prokidney Current Liabilities

The Current Liabilities of Prokidney (PROK) as of Nov 15, 2026 is 29.67 M USD. In the previous year, Current Liabilities was 67.44 M USD — a change of -56.01% (lower).

Current Liabilities

29.67 MUSD

YoY

-56.01%

Last updated:

Current Liabilities of Prokidney is 2025 29.67 M USD. Current Liabilities of Prokidney was 2024 67.44 M USD. It decreases by -56.01% lower compared to the previous year.

The Prokidney Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
2.71 M USD
Jan 1, 2020
7.30 M USD
Jan 1, 2021
17.35 M USD
Jan 1, 2022
21.75 M USD
Jan 1, 2023
42.03 M USD
Jan 1, 2024
67.44 M USD
Jan 1, 2025
29.67 M USD
The Prokidney Current Liabilities history
YEARCurrent LiabilitiesYoY
29.67 MUSD-56.01%
67.44 MUSD+60.43%
42.03 MUSD+93.26%
21.75 MUSD+25.39%
17.35 MUSD+137.55%
7.30 MUSD+169.05%
2.71 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prokidney Stock analysis

What does Prokidney do? Prokidney Corp, based in Winston-Salem, North Carolina, is a clinical-stage biotechnology company focused on developing cell therapy platforms for chronic kidney diseases. The company employs 231 people and is listed on the stock market since June 30, 2021. Its lead product, Renal Autologous Cell Therapy (REACT), uses a patient's own kidney cells to preserve kidney function in chronic kidney disease patients. REACT is currently in global Phase 3 trials and multiple Phase 2 trials for diabetic kidney disease. Prokidney is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prokidney stock

Current Liabilities of Prokidney is 29.67 M USD in 2025.

Current Liabilities of Prokidney changed from 67.44 M USD to 29.67 M USD, representing a -56.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Prokidney since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Prokidney historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Prokidney

All Key Metrics — Prokidney